Karen E. Bremner

3.0k total citations
95 papers, 2.2k citations indexed

About

Karen E. Bremner is a scholar working on Economics and Econometrics, Oncology and Epidemiology. According to data from OpenAlex, Karen E. Bremner has authored 95 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Economics and Econometrics, 20 papers in Oncology and 16 papers in Epidemiology. Recurrent topics in Karen E. Bremner's work include Health Systems, Economic Evaluations, Quality of Life (31 papers), Economic and Financial Impacts of Cancer (15 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Karen E. Bremner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (31 papers), Economic and Financial Impacts of Cancer (15 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Karen E. Bremner collaborates with scholars based in Canada, United States and Austria. Karen E. Bremner's co-authors include Murray Krahn, C. A. Naranjo, George Tomlinson, Gary Naglie, Krista L. Lanctôt, Claudio A. Naranjo, Jeffrey S. Hoch, Shabbir M.H. Alibhai, Constantine X. Poulos and Paul Ritvo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Karen E. Bremner

90 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen E. Bremner Canada 29 649 483 457 432 265 95 2.2k
Brittany Lapin United States 30 182 0.3× 282 0.6× 529 1.2× 437 1.0× 66 0.2× 184 3.1k
Carol Forbes United Kingdom 20 234 0.4× 373 0.8× 364 0.8× 143 0.3× 31 0.1× 34 1.9k
Katy Bell Australia 29 361 0.6× 734 1.5× 365 0.8× 484 1.1× 78 0.3× 159 3.6k
S. Pampallona Switzerland 30 118 0.2× 779 1.6× 311 0.7× 476 1.1× 41 0.2× 81 3.3k
Y Dündar United Kingdom 35 319 0.5× 511 1.1× 201 0.4× 697 1.6× 30 0.1× 94 3.1k
Richard R. Reich United States 25 170 0.3× 1.1k 2.2× 337 0.7× 599 1.4× 20 0.1× 88 2.9k
Ning Liu Canada 24 167 0.3× 1.1k 2.3× 1.0k 2.2× 276 0.6× 37 0.1× 174 2.8k
Nigel S. B. Rawson Canada 22 322 0.5× 331 0.7× 410 0.9× 224 0.5× 23 0.1× 85 2.0k
Ching‐Chih Lee Taiwan 31 105 0.2× 655 1.4× 498 1.1× 504 1.2× 30 0.1× 136 2.7k
Jipan Xie United States 24 351 0.5× 485 1.0× 304 0.7× 370 0.9× 14 0.1× 133 2.4k

Countries citing papers authored by Karen E. Bremner

Since Specialization
Citations

This map shows the geographic impact of Karen E. Bremner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Bremner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Bremner more than expected).

Fields of papers citing papers by Karen E. Bremner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Bremner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Bremner. The network helps show where Karen E. Bremner may publish in the future.

Co-authorship network of co-authors of Karen E. Bremner

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Bremner. A scholar is included among the top collaborators of Karen E. Bremner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Bremner. Karen E. Bremner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krahn, Murray, Fangyun Wu, Matthew B. Stanbrook, et al.. (2025). Understanding the Growing Burden of Malignant Pleural Effusion – Epidemiology, Healthcare Utilization, and Cost: A Canadian Perspective. Respiration. 104(6). 421–433. 1 indexed citations
2.
3.
Krahn, Murray, et al.. (2024). INCREMENTAL HEALTH CARE UTILIZATION AND COST OF MALIGNANT PLEURAL EFFUSION. CHEST Journal. 166(4). A3650–A3651.
4.
Cheung, Douglas C., Karen E. Bremner, Reka Pataky, et al.. (2023). The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis. PLoS ONE. 18(9). e0290646–e0290646. 11 indexed citations
5.
Wong, William, Josephine Wong, Karen E. Bremner, et al.. (2023). Impact of direct‐acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings. Liver International. 43(4). 805–818. 2 indexed citations
6.
Alibhai, Shabbir M.H., Efthymios Papadopoulos, Daniel Santa Mina, et al.. (2023). Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis. Journal of Geriatric Oncology. 15(1). 101646–101646. 2 indexed citations
7.
8.
Xie, Xuanqian, et al.. (2021). Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes. Journal of Comparative Effectiveness Research. 10(13). 961–974. 4 indexed citations
9.
Oliveira, Claire de, Reka Pataky, Karen E. Bremner, et al.. (2016). Phase-specific and lifetime costs of cancer care in Ontario, Canada. BMC Cancer. 16(1). 809–809. 100 indexed citations
10.
Oliveira, Claire de, Karen E. Bremner, Ning Liu, et al.. (2016). Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada. Value in Health. 20(3). 345–356. 23 indexed citations
11.
Pataky, Reka, Winson Y. Cheung, Claire de Oliveira, et al.. (2016). Population-Based Trends in Systemic Therapy Use and Cost for Cancer Patients in the Last Year of Life. Current Oncology. 23(11). 32–41. 18 indexed citations
12.
Mühlberger, Nikolai, Eveline A.M. Heijnsdijk, Christina Kurzthaler, et al.. (2014). The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. Value in Health. 17(7). A559–A559. 1 indexed citations
13.
Oliveira, Claire de, Karen E. Bremner, Reka Pataky, et al.. (2013). Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study. CMAJ Open. 1(4). E151–E158. 38 indexed citations
14.
Krahn, Murray, Brandon Zagorski, Audrey Laporte, et al.. (2009). Healthcare costs associated with prostate cancer: estimates from a population‐based study. British Journal of Urology. 105(3). 338–346. 83 indexed citations
15.
Krahn, Murray, Karen E. Bremner, George Tomlinson, et al.. (2006). Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Quality of Life Research. 16(3). 509–522. 74 indexed citations
16.
Konski, André, Eric J. Sherman, Murray Krahn, et al.. (2005). Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10). International Journal of Radiation Oncology*Biology*Physics. 63(3). 788–794. 26 indexed citations
17.
Naranjo, C. A., Karen E. Bremner, & Krista L. Lanctôt. (2003). Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems. Addiction. 90(1). 87–99. 23 indexed citations
18.
Bremner, Karen E., et al.. (1996). Research strategies to assess pharmacotherapies for alcoholism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20(4). 543–559. 1 indexed citations
19.
Naranjo, C. A. & Karen E. Bremner. (1994). Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications. Birkhäuser Basel eBooks. 71. 209–219. 28 indexed citations
20.
Goldbloom, David S., Claudio A. Naranjo, Karen E. Bremner, & Lisa K. Hicks. (1992). Eating disorders and alcohol abuse in women. British Journal of Addiction. 87(6). 913–920. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brittany Lapin Breakdown of academic impact, for papers by Carol Forbes Breakdown of academic impact, for papers by Katy Bell Breakdown of academic impact, for papers by S. Pampallona Breakdown of academic impact, for papers by Y Dündar Breakdown of academic impact, for papers by Richard R. Reich Breakdown of academic impact, for papers by Ning Liu Breakdown of academic impact, for papers by Nigel S. B. Rawson Breakdown of academic impact, for papers by Ching‐Chih Lee Breakdown of academic impact, for papers by Jipan Xie
Rankless by CCL
2026